Contineum Therapeutics, Inc. Class A Ownership | Who Owns Contineum Therapeutics, Inc. Class A?
Contineum Therapeutics, Inc. Class A Ownership Summary
Contineum Therapeutics, Inc. Class A is owned by 81.55% institutional investors, 6.94% insiders, and 11.51% retail investors.
CTNM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Contineum Therapeutics, Inc. Class A | 81.55% | 6.94% | 11.51% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 60 | 17.65% | 15,782,189 | 16.07% | 81 | 2.92% | 40 | 66.67% | 9 | -40.00% |
| Sep 30, 2024 | 51 | 4.08% | 13,597,553 | 4.46% | 52 | 2.06% | 24 | -51.02% | 15 | - |
| Jun 30, 2024 | 49 | - | 13,016,510 | - | 50 | - | 49 | - | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 25, 2024 | Lorrain Daniel S. | Chief Scientific Officer | Sell | $16.18K |
| Nov 18, 2024 | Lorrain Daniel S. | Chief Scientific Officer | Sell | $99.73K |
| Nov 18, 2024 | Lorrain Daniel S. | Chief Scientific Officer | Sell | $1.69K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | - | 3 |
| 2024 Q2 | - | - |
CTNM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools